Filter
910
Filtered Results: 910
Text search:
sérologie
Featured
Recommendations
116
New Publications
249
Language
Document type
No document type
491
Guidelines
202
Studies & Reports
107
Manuals
38
Fact sheets
33
Strategic & Response Plan
22
Situation Updates
7
Infographics
5
Training Material
3
Brochures
1
Resource Platforms
1
Countries / Regions
Global
37
Germany
35
India
32
Africa
22
South Africa
20
Latin America and the Carribbean
19
Western and Central Europe
19
Nigeria
18
Congo, Democratic Republic of
17
Philippines
16
Senegal
15
Bangladesh
15
Ethiopia
13
Indonesia
10
West and Central Africa
10
Burkina Faso
9
Sierra Leone
9
Nepal
9
Kenya
9
Tanzania
9
Rwanda
9
Mozambique
9
Central African Republic
9
Brazil
9
East and Southern Africa
9
Guinea
8
Zambia
8
Uganda
7
Haiti
6
Madagascar
6
Eastern Europe
6
Liberia
5
Cameroon
5
Malawi
5
Benin
5
Ukraine
5
Colombia
5
Myanmar / Burma
5
Middle East and North Africa
5
Venezuela
5
Russia
5
Ghana
4
Pakistan
4
Syria
4
Peru
4
Angola
4
Lesotho
4
South–East Asia Region
4
Paraguay
4
Asia
4
France
4
Côte d’Ivoire / Ivory Coast
3
USA
3
Afghanistan
3
Cambodia
3
China
3
Namibia
3
Ecuador
3
Vietnam
3
Mali
2
Saudi Arabia
2
Zimbabwe
2
South Sudan
2
Iraq
2
Jordan
2
Lebanon
2
Turkey
2
Egypt
2
Sudan
2
Argentina
2
North Macedonia
2
Bolivia
2
Mexico
2
Eastern Europe and Central Asia
2
Albania
2
Iran
2
Portugal
2
Guinea-Bissau
1
Morocco
1
Togo
1
Somalia
1
Chad
1
Papua New Guinea
1
Honduras
1
Botswana
1
Greece
1
Libya
1
Sri Lanka
1
Yemen
1
Bhutan
1
Palestine
1
Italy
1
Djibouti
1
Laos
1
Tajikistan
1
Qatar
1
Georgia
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
330
Clinical Guidelines
147
Pharmacy & Technologies
42
Public Health
27
Women & Child Health
18
Key Resources
15
Capacity Building
5
Toolboxes
COVID-19
124
NTDs
104
HIV
95
Rapid Response
82
Zika
54
Ebola
39
TB
37
Refugee
23
AMR
12
Planetary Health
12
Pharmacy
11
Mental Health
9
Caregiver
9
Polio
8
Cholera
7
Natural Hazards
3
Global Health Education
3
Disability
2
Conflict
2
NCDs
2
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
